Rimm IJ - Search Results

1

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E 3rd, Kadin M, Antin J. Wheeler C, et al. Among authors: rimm ij. Biol Blood Marrow Transplant. 1997 Jun;3(2):98-106. Biol Blood Marrow Transplant. 1997. PMID: 9267670 Clinical Trial.

2

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.

Ballen KK, Gilliland DG, Guinan EC, Hsieh CC, Parsons SK, Rimm IJ, Ferrara JL, Bierer BE, Weinstein HJ, Antin JH. Ballen KK, et al. Among authors: rimm ij. Bone Marrow Transplant. 1997 Nov;20(9):737-43. doi: 10.1038/sj.bmt.1700971. Bone Marrow Transplant. 1997. PMID: 9384475 Clinical Trial.

3

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

Antin JH, Weinstein HJ, Guinan EC, McCarthy P, Bierer BE, Gilliland DG, Parsons SK, Ballen KK, Rimm IJ, Falzarano G, et al. Antin JH, et al. Among authors: rimm ij. Blood. 1994 Aug 15;84(4):1342-8. Blood. 1994. PMID: 8049450 Free article.

4

TCR-beta transgenic mice fail to mediate a GVHR due to defects of allorecognition and subsequent IL-2 generation.

Rimm IJ, Krenger W, Beland JL, Geller MC, Di Savino E, Yui K, Katsumata M, Ferrara JL. Rimm IJ, et al. Bone Marrow Transplant. 1996 May;17(5):835-42. Bone Marrow Transplant. 1996. PMID: 8733706

5

Alloreactive lymphocytes from T cell receptor (beta-chain) transgenic mice do not mediate a graft-versus-host reaction.

Rimm IJ, Ghayur T, Gasser DL, Rosenkrantz K, Burakoff SJ, Seidman JG, Ferrara JL. Rimm IJ, et al. J Immunol. 1991 Feb 15;146(4):1130-3. J Immunol. 1991. PMID: 1825104

6

A role for transforming growth factor-beta1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus-host disease after pulmonary herpes simplex virus type 1 infection.

Adler H, Beland JL, Kozlow W, Del-Pan NC, Kobzik L, Rimm IJ. Adler H, et al. Among authors: rimm ij. Blood. 1998 Oct 1;92(7):2581-9. Blood. 1998. PMID: 9746800 Free article.

7

Bone marrow transplantation for the Wiskott-Aldrich syndrome. Long-term follow-up.

Rimm IJ, Rappeport JM. Rimm IJ, et al. Transplantation. 1990 Oct;50(4):617-20. doi: 10.1097/00007890-199010000-00018. Transplantation. 1990. PMID: 2219285

8

Recombinant CD40L treatment protects allogeneic murine bone marrow transplant recipients from death caused by herpes simplex virus-1 infection.

Beland JL, Adler H, Del-Pan NC, Kozlow W, Sung J, Fanslow W, Rimm IJ. Beland JL, et al. Among authors: rimm ij. Blood. 1998 Dec 1;92(11):4472-8. Blood. 1998. PMID: 9834255 Free article.

9

Insights into the mechanism of allograft acceptance in T-cell receptor (beta-chain) transgenic mice.

Barrett LV, Rimm IJ, Wiens GR, Seidman JG, Kirkman RL. Barrett LV, et al. Among authors: rimm ij. Transplant Proc. 1993 Feb;25(1 Pt 1):366-7. Transplant Proc. 1993. PMID: 8438338 No abstract available.

10

T cell receptor (beta chain) transgenic mice have selective deficits in gamma delta T cell subpopulations.

Rimm IJ, Fruman DA, Abhyankar S, Sakamoto H, Orme IM, Milstone D, Seidman JG, Ferrara JL. Rimm IJ, et al. Transpl Immunol. 1994 Sep;2(3):218-24. doi: 10.1016/0966-3274(94)90063-9. Transpl Immunol. 1994. PMID: 8000850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters